drugset / Trial / NCT01318655

Single and Multiple Ascending Dose Study for NKTR-118 and Cross-over Study to Investigate the Effect of Food for NKTR-118 in Japanese Healthy Subjects

NCT01318655

Phase 1 Completed 50 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the safety and tolerability of NKTR-118 with healthy subjects.

Timeline

Start
2011-03
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxegol Small molecule Oral

Indications

No indication recorded.